Pre-Eclampsia
·MeSH: Pre-Eclampsia
Prevalence
30.0 / 100K
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| DM199 | DiaMedica Therapeutics Inc. (DMAC) |
Frequently asked questions
How many drugs are in development for Pre-Eclampsia?
BioSniper tracks 1 drug in development for Pre-Eclampsia across 1 company.
How many clinical trials target Pre-Eclampsia?
There are 3 clinical trials targeting Pre-Eclampsia tracked by BioSniper.
What is the prevalence of Pre-Eclampsia?
The estimated prevalence of Pre-Eclampsia is approximately 30.0 per 100,000 population.
Deep-dive into Pre-Eclampsia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis